Global Cold Remedies

Cold Remedies Comprehensive Study by Drug (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets/Hypermarkets, E-Commerce/Online Pharmacies), Dosage (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges) Players and Region - Global Market Outlook to 2028

Cold Remedies Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Cold Remedies Market Scope
Cold is an infectious disease that affects the respiratory system. The common symptoms for cold include sneezing, sore throat, a stuffy nose, and coughing. Cold remedies are used to treat cold in immunosuppressed individuals. The composition of many cold medicines are same and therefore taking too much of certain medication can lead to drug resistance or serious injury.



The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Cold Remedies market throughout the predicted period.

Reckitt Benckiser Group (United Kingdom), Johnson & Johnson (United States), GlaxoSmithKline (United Kingdom), Novartis (Switzerland), Bayer (Germany), AstraZeneca (United Kingdom), Sun Pharmaceutical Industries (India), Pfizer (United States), Prestige Brands Holdings (United States) and Procter & Gamble (United States) are some of the key players that are part of study coverage.

Segmentation Overview
The study have segmented the market of Global Cold Remedies market and Region with country level break-up.

On the basis of geography, the market of Cold Remedies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increasing Demand of Over-The-Counter Products

Market Growth Drivers:
Increasing Number of Cold Cases and Growing Geriatric Population

Challenges:
Side Effects Related to Cold Remedies

Restraints:
Competition Faced by International Players due to Drugs from Local Manufacturers

Opportunities:
Favorable Regulations and Opportunities in the Emerging Economies and Development in R&D Activities Associated With Cough Remedies


The U.S. Food and Drug Administration (FDA) is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18. FDA is also requiring the addition of safety information about the risks of misuse, abuse, addiction, overdose, death, and slowed or difficult breathing to the Boxed Warning, our most prominent warning, of the drug labels for prescription cough and cold medicines containing codeine or hydrocodone

Key Target Audience
Manufacturers of Cold Remedies, Suppliers of Cold Remedies, Distributers of Cold Remedies, Healthcare industry, Governmental bodies and Research Firms

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Drug
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • E-Commerce/Online Pharmacies

By Dosage
  • Oral Syrups
  • Tablets/Pills
  • Nasal Drops
  • Lozenges

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Cold Cases
      • 3.2.2. Growing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Related to Cold Remedies
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand of Over-The-Counter Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cold Remedies, by Drug, Distribution Channel, Dosage and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Cold Remedies (Value)
      • 5.2.1. Global Cold Remedies by: Drug (Value)
        • 5.2.1.1. Antihistamines
        • 5.2.1.2. Expectorants
        • 5.2.1.3. Bronchodilators
        • 5.2.1.4. Decongestants
        • 5.2.1.5. Antibiotics
      • 5.2.2. Global Cold Remedies by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Drug Stores
        • 5.2.2.4. Supermarkets/Hypermarkets
        • 5.2.2.5. E-Commerce/Online Pharmacies
      • 5.2.3. Global Cold Remedies by: Dosage (Value)
        • 5.2.3.1. Oral Syrups
        • 5.2.3.2. Tablets/Pills
        • 5.2.3.3. Nasal Drops
        • 5.2.3.4. Lozenges
      • 5.2.4. Global Cold Remedies Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Cold Remedies (Price)
  • 6. Cold Remedies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Reckitt Benckiser Group (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AstraZeneca (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sun Pharmaceutical Industries (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pfizer (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Prestige Brands Holdings (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Procter & Gamble (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cold Remedies Sale, by Drug, Distribution Channel, Dosage and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Cold Remedies (Value)
      • 7.2.1. Global Cold Remedies by: Drug (Value)
        • 7.2.1.1. Antihistamines
        • 7.2.1.2. Expectorants
        • 7.2.1.3. Bronchodilators
        • 7.2.1.4. Decongestants
        • 7.2.1.5. Antibiotics
      • 7.2.2. Global Cold Remedies by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Drug Stores
        • 7.2.2.4. Supermarkets/Hypermarkets
        • 7.2.2.5. E-Commerce/Online Pharmacies
      • 7.2.3. Global Cold Remedies by: Dosage (Value)
        • 7.2.3.1. Oral Syrups
        • 7.2.3.2. Tablets/Pills
        • 7.2.3.3. Nasal Drops
        • 7.2.3.4. Lozenges
      • 7.2.4. Global Cold Remedies Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Cold Remedies (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cold Remedies: by Drug(USD Million)
  • Table 2. Cold Remedies Antihistamines , by Region USD Million (2017-2022)
  • Table 3. Cold Remedies Expectorants , by Region USD Million (2017-2022)
  • Table 4. Cold Remedies Bronchodilators , by Region USD Million (2017-2022)
  • Table 5. Cold Remedies Decongestants , by Region USD Million (2017-2022)
  • Table 6. Cold Remedies Antibiotics , by Region USD Million (2017-2022)
  • Table 7. Cold Remedies: by Distribution Channel(USD Million)
  • Table 8. Cold Remedies Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 9. Cold Remedies Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 10. Cold Remedies Drug Stores , by Region USD Million (2017-2022)
  • Table 11. Cold Remedies Supermarkets/Hypermarkets , by Region USD Million (2017-2022)
  • Table 12. Cold Remedies E-Commerce/Online Pharmacies , by Region USD Million (2017-2022)
  • Table 13. Cold Remedies: by Dosage(USD Million)
  • Table 14. Cold Remedies Oral Syrups , by Region USD Million (2017-2022)
  • Table 15. Cold Remedies Tablets/Pills , by Region USD Million (2017-2022)
  • Table 16. Cold Remedies Nasal Drops , by Region USD Million (2017-2022)
  • Table 17. Cold Remedies Lozenges , by Region USD Million (2017-2022)
  • Table 18. South America Cold Remedies, by Country USD Million (2017-2022)
  • Table 19. South America Cold Remedies, by Drug USD Million (2017-2022)
  • Table 20. South America Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 21. South America Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 22. Brazil Cold Remedies, by Drug USD Million (2017-2022)
  • Table 23. Brazil Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 24. Brazil Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 25. Argentina Cold Remedies, by Drug USD Million (2017-2022)
  • Table 26. Argentina Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 27. Argentina Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 28. Rest of South America Cold Remedies, by Drug USD Million (2017-2022)
  • Table 29. Rest of South America Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 30. Rest of South America Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 31. Asia Pacific Cold Remedies, by Country USD Million (2017-2022)
  • Table 32. Asia Pacific Cold Remedies, by Drug USD Million (2017-2022)
  • Table 33. Asia Pacific Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 34. Asia Pacific Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 35. China Cold Remedies, by Drug USD Million (2017-2022)
  • Table 36. China Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 37. China Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 38. Japan Cold Remedies, by Drug USD Million (2017-2022)
  • Table 39. Japan Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 40. Japan Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 41. India Cold Remedies, by Drug USD Million (2017-2022)
  • Table 42. India Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 43. India Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 44. South Korea Cold Remedies, by Drug USD Million (2017-2022)
  • Table 45. South Korea Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 46. South Korea Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 47. Taiwan Cold Remedies, by Drug USD Million (2017-2022)
  • Table 48. Taiwan Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 49. Taiwan Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 50. Australia Cold Remedies, by Drug USD Million (2017-2022)
  • Table 51. Australia Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 52. Australia Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Cold Remedies, by Drug USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 56. Europe Cold Remedies, by Country USD Million (2017-2022)
  • Table 57. Europe Cold Remedies, by Drug USD Million (2017-2022)
  • Table 58. Europe Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 59. Europe Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 60. Germany Cold Remedies, by Drug USD Million (2017-2022)
  • Table 61. Germany Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 62. Germany Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 63. France Cold Remedies, by Drug USD Million (2017-2022)
  • Table 64. France Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 65. France Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 66. Italy Cold Remedies, by Drug USD Million (2017-2022)
  • Table 67. Italy Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 68. Italy Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 69. United Kingdom Cold Remedies, by Drug USD Million (2017-2022)
  • Table 70. United Kingdom Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 71. United Kingdom Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 72. Netherlands Cold Remedies, by Drug USD Million (2017-2022)
  • Table 73. Netherlands Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 74. Netherlands Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 75. Rest of Europe Cold Remedies, by Drug USD Million (2017-2022)
  • Table 76. Rest of Europe Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 77. Rest of Europe Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 78. MEA Cold Remedies, by Country USD Million (2017-2022)
  • Table 79. MEA Cold Remedies, by Drug USD Million (2017-2022)
  • Table 80. MEA Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 81. MEA Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 82. Middle East Cold Remedies, by Drug USD Million (2017-2022)
  • Table 83. Middle East Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 84. Middle East Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 85. Africa Cold Remedies, by Drug USD Million (2017-2022)
  • Table 86. Africa Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 87. Africa Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 88. North America Cold Remedies, by Country USD Million (2017-2022)
  • Table 89. North America Cold Remedies, by Drug USD Million (2017-2022)
  • Table 90. North America Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 91. North America Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 92. United States Cold Remedies, by Drug USD Million (2017-2022)
  • Table 93. United States Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 94. United States Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 95. Canada Cold Remedies, by Drug USD Million (2017-2022)
  • Table 96. Canada Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 97. Canada Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 98. Mexico Cold Remedies, by Drug USD Million (2017-2022)
  • Table 99. Mexico Cold Remedies, by Distribution Channel USD Million (2017-2022)
  • Table 100. Mexico Cold Remedies, by Dosage USD Million (2017-2022)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Cold Remedies: by Drug(USD Million)
  • Table 112. Cold Remedies Antihistamines , by Region USD Million (2023-2028)
  • Table 113. Cold Remedies Expectorants , by Region USD Million (2023-2028)
  • Table 114. Cold Remedies Bronchodilators , by Region USD Million (2023-2028)
  • Table 115. Cold Remedies Decongestants , by Region USD Million (2023-2028)
  • Table 116. Cold Remedies Antibiotics , by Region USD Million (2023-2028)
  • Table 117. Cold Remedies: by Distribution Channel(USD Million)
  • Table 118. Cold Remedies Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 119. Cold Remedies Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 120. Cold Remedies Drug Stores , by Region USD Million (2023-2028)
  • Table 121. Cold Remedies Supermarkets/Hypermarkets , by Region USD Million (2023-2028)
  • Table 122. Cold Remedies E-Commerce/Online Pharmacies , by Region USD Million (2023-2028)
  • Table 123. Cold Remedies: by Dosage(USD Million)
  • Table 124. Cold Remedies Oral Syrups , by Region USD Million (2023-2028)
  • Table 125. Cold Remedies Tablets/Pills , by Region USD Million (2023-2028)
  • Table 126. Cold Remedies Nasal Drops , by Region USD Million (2023-2028)
  • Table 127. Cold Remedies Lozenges , by Region USD Million (2023-2028)
  • Table 128. South America Cold Remedies, by Country USD Million (2023-2028)
  • Table 129. South America Cold Remedies, by Drug USD Million (2023-2028)
  • Table 130. South America Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 131. South America Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 132. Brazil Cold Remedies, by Drug USD Million (2023-2028)
  • Table 133. Brazil Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 134. Brazil Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 135. Argentina Cold Remedies, by Drug USD Million (2023-2028)
  • Table 136. Argentina Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 137. Argentina Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 138. Rest of South America Cold Remedies, by Drug USD Million (2023-2028)
  • Table 139. Rest of South America Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 140. Rest of South America Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 141. Asia Pacific Cold Remedies, by Country USD Million (2023-2028)
  • Table 142. Asia Pacific Cold Remedies, by Drug USD Million (2023-2028)
  • Table 143. Asia Pacific Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 144. Asia Pacific Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 145. China Cold Remedies, by Drug USD Million (2023-2028)
  • Table 146. China Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 147. China Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 148. Japan Cold Remedies, by Drug USD Million (2023-2028)
  • Table 149. Japan Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 150. Japan Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 151. India Cold Remedies, by Drug USD Million (2023-2028)
  • Table 152. India Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 153. India Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 154. South Korea Cold Remedies, by Drug USD Million (2023-2028)
  • Table 155. South Korea Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 156. South Korea Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 157. Taiwan Cold Remedies, by Drug USD Million (2023-2028)
  • Table 158. Taiwan Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 159. Taiwan Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 160. Australia Cold Remedies, by Drug USD Million (2023-2028)
  • Table 161. Australia Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 162. Australia Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 163. Rest of Asia-Pacific Cold Remedies, by Drug USD Million (2023-2028)
  • Table 164. Rest of Asia-Pacific Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 165. Rest of Asia-Pacific Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 166. Europe Cold Remedies, by Country USD Million (2023-2028)
  • Table 167. Europe Cold Remedies, by Drug USD Million (2023-2028)
  • Table 168. Europe Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 169. Europe Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 170. Germany Cold Remedies, by Drug USD Million (2023-2028)
  • Table 171. Germany Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 172. Germany Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 173. France Cold Remedies, by Drug USD Million (2023-2028)
  • Table 174. France Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 175. France Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 176. Italy Cold Remedies, by Drug USD Million (2023-2028)
  • Table 177. Italy Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 178. Italy Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 179. United Kingdom Cold Remedies, by Drug USD Million (2023-2028)
  • Table 180. United Kingdom Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 181. United Kingdom Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 182. Netherlands Cold Remedies, by Drug USD Million (2023-2028)
  • Table 183. Netherlands Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 184. Netherlands Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 185. Rest of Europe Cold Remedies, by Drug USD Million (2023-2028)
  • Table 186. Rest of Europe Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 187. Rest of Europe Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 188. MEA Cold Remedies, by Country USD Million (2023-2028)
  • Table 189. MEA Cold Remedies, by Drug USD Million (2023-2028)
  • Table 190. MEA Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 191. MEA Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 192. Middle East Cold Remedies, by Drug USD Million (2023-2028)
  • Table 193. Middle East Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 194. Middle East Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 195. Africa Cold Remedies, by Drug USD Million (2023-2028)
  • Table 196. Africa Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 197. Africa Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 198. North America Cold Remedies, by Country USD Million (2023-2028)
  • Table 199. North America Cold Remedies, by Drug USD Million (2023-2028)
  • Table 200. North America Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 201. North America Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 202. United States Cold Remedies, by Drug USD Million (2023-2028)
  • Table 203. United States Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 204. United States Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 205. Canada Cold Remedies, by Drug USD Million (2023-2028)
  • Table 206. Canada Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 207. Canada Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 208. Mexico Cold Remedies, by Drug USD Million (2023-2028)
  • Table 209. Mexico Cold Remedies, by Distribution Channel USD Million (2023-2028)
  • Table 210. Mexico Cold Remedies, by Dosage USD Million (2023-2028)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cold Remedies: by Drug USD Million (2017-2022)
  • Figure 5. Global Cold Remedies: by Distribution Channel USD Million (2017-2022)
  • Figure 6. Global Cold Remedies: by Dosage USD Million (2017-2022)
  • Figure 7. South America Cold Remedies Share (%), by Country
  • Figure 8. Asia Pacific Cold Remedies Share (%), by Country
  • Figure 9. Europe Cold Remedies Share (%), by Country
  • Figure 10. MEA Cold Remedies Share (%), by Country
  • Figure 11. North America Cold Remedies Share (%), by Country
  • Figure 12. Global Cold Remedies share by Players 2022 (%)
  • Figure 13. Global Cold Remedies share by Players (Top 3) 2022(%)
  • Figure 14. Global Cold Remedies share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Reckitt Benckiser Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Reckitt Benckiser Group (United Kingdom) Revenue: by Geography 2022
  • Figure 18. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 19. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 20. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2022
  • Figure 22. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Novartis (Switzerland) Revenue: by Geography 2022
  • Figure 24. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Bayer (Germany) Revenue: by Geography 2022
  • Figure 26. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. AstraZeneca (United Kingdom) Revenue: by Geography 2022
  • Figure 28. Sun Pharmaceutical Industries (India) Revenue, Net Income and Gross profit
  • Figure 29. Sun Pharmaceutical Industries (India) Revenue: by Geography 2022
  • Figure 30. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 31. Pfizer (United States) Revenue: by Geography 2022
  • Figure 32. Prestige Brands Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 33. Prestige Brands Holdings (United States) Revenue: by Geography 2022
  • Figure 34. Procter & Gamble (United States) Revenue, Net Income and Gross profit
  • Figure 35. Procter & Gamble (United States) Revenue: by Geography 2022
  • Figure 36. Global Cold Remedies: by Drug USD Million (2023-2028)
  • Figure 37. Global Cold Remedies: by Distribution Channel USD Million (2023-2028)
  • Figure 38. Global Cold Remedies: by Dosage USD Million (2023-2028)
  • Figure 39. South America Cold Remedies Share (%), by Country
  • Figure 40. Asia Pacific Cold Remedies Share (%), by Country
  • Figure 41. Europe Cold Remedies Share (%), by Country
  • Figure 42. MEA Cold Remedies Share (%), by Country
  • Figure 43. North America Cold Remedies Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Reckitt Benckiser Group (United Kingdom)
  • Johnson & Johnson (United States)
  • GlaxoSmithKline (United Kingdom)
  • Novartis (Switzerland)
  • Bayer (Germany)
  • AstraZeneca (United Kingdom)
  • Sun Pharmaceutical Industries (India)
  • Pfizer (United States)
  • Prestige Brands Holdings (United States)
  • Procter & Gamble (United States)
Select User Access Type

Key Highlights of Report


May 2023 213 Pages 61 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cold Remedies Quantitative research analysis
Global Cold Remedies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Cold Remedies study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Cold Remedies Market is gaining popularity and expected to see strong valuation by 2028 .
According to AMA, the Global Cold Remedies market is expected to see growth rate of xx%.
The Cold Remedies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Cold Remedies Report?

Have a Query? Click Here

Other Related Reports

Botanical and Plant-Derived Drugs Comprehensive Study by Type (Terpenes, Steroids, Glycosides, Phenols), Application (Oncology, Dermatology, CNS disorders, Hormone diseases) Players and Region - Glob...
$ 3500
Dry Eye Drugs Comprehensive Study by Type (Artificial Tears, Anti-inflammatory Drugs), Application (Hospital Pharmacies, Drug Stores, Online Pharmacies), Treatment (Topical Cyclosporine A Eye Drops, ...
$ 3750
Optic Neuropathy Drug Comprehensive Study by Type (BA-240, IWP-953, LM-22A4, Others), Application (Hospitals, Ophthalmic clinics, Ambulatory Surgical Centres), Distribution Channel (Prescription Drug...
$ 3350
Sexual Enhancement Supplements Comprehensive Study by Type (Male Sexual Enhancement Supplements, Female Sexual Enhancement Supplements), Application (Individual Use, Commercial Use), Distribution Cha...
$ 3750
Fetal Bovine Serum Comprehensive Study by Application (Drug Discovery, Cell Culture Media, Vitro Fertilization, Human and Animal Vaccine production, Diagnostics, Others), End-Users (Research and Acad...
$ 3450
Pharma Track and Trace Solutions Comprehensive Study by Application (Serialization, Aggregations, Reporting), By components (Software, Services), By Technology (Barcodes, RFID), End User (BioPharma, ...
$ 3350